Ncardia is a stem cell drug discovery & development company operating worldwide with facilities and offices in Belgium, The Netherlands and the USA. Ncardia is a leading contract research organisation in human cardiovascular and neural stem cell drug discovery, encompassing disease modeling, iPSC manufacturing and iPSC-based screening.
"Ncardia" (Greek): FROM THE HEART
Our passion for innovation
Ncardia believes that stem cell technology fast-tracks the delivery of better medicines to patients by improving the drug discovery process. We develop, produce and commercialize highly-predictive human cellular (disease) assay systems for safety and efficacy testing aiming to accelerate and improve drug candidate selection, reduce costs and ultimately increase drug discovery and development efficiency.
Our Drug Discovery Solutions
Ncardia provides its customers with a broad portfolio of cardiovascular and neural iPSC services for safety and efficacy testing and analysis. Our DiscoverHIT Screening Platform provides a flexible solution for bringing hiPSC disease models into predictive assays suitable for drug discovery (screening) campaigns.The safety services are pre-configured service packages based on electrophysiology, biochemistry and contraction assay technology for predictive safety pharmacology and toxicology testing.
Our iPSC Manufacturing Solutions
Ncardia specializes in iPSC-derived cardiac, vascular and CNS cell manufacturing. With our over 15 years of experience in developing manufacturing processes for induced pluripotent stem cells, Ncardia is exceptionally well equipped to design, optimize and scale manufacturing processes.
Visit www.ncardia.com to learn more about how iPSC technology can increase predictability in your drug discovery project.
0
Total investors
0
Early stage
0
Mid stage
0
Late stage
2011
Founded
Investors
0 investors
All
Early stage
Mid stage
Late stage
No investors in this category
Frequently asked questions
When was Ncardia founded?
Ncardia was founded in 2011.
Where is Ncardia based?
Ncardia is headquartered in Gosselies, Belgium.
Find investors for your startup like Ncardia
Gritt sends AI-personalised outreach to each investor — from your Gmail